US Stock MarketDetailed Quotes
RNLX Renalytix
- 0.196
- +0.014+7.69%
Close Oct 4 16:00 ET
- 0.191
- -0.005-2.60%
Post 20:02 ET
16.26MMarket Cap-316P/E (TTM)
0.200High0.176Low284.56KVolume0.189Open0.182Pre Close51.85KTurnover0.50%Turnover RatioLossP/E (Static)82.96MShares2.40052wk High-2.06P/B11.21MFloat Cap0.17652wk Low--Dividend TTM57.17MShs Float35.710Historical High--Div YieldTTM13.19%Amplitude0.176Historical Low0.182Avg Price1Lot Size
About Renalytix Company
Renalytix AI Plc manufactures medical devices and equipment. It offers artificial intelligence for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in Penarth, the United Kingdom.
Company Profile
SymbolRNLX
Company NameRenalytix
Issue Price13.50
Founded2018
CEOMr. James Renwick McCullough
MarketNASDAQ
Employees93
Securities TypeDR
ADS Ratio1.0 : 2.0
Fiscal Year Ends06-30
AddressAvon House,19 Stanwell Road
CityPenarth
ProvinceCardiff
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeCF64 2EZ
Phone44-20-3139-2910
Websitehttps://renalytixai.com/
Company Executives
- Name
- Position
- Salary
- James Renwick McCullough
- Chairman of the Board and Chief Executive Officer
- 780.11K
- Joel R. Jung
- Interim Chief Financial Officer and Principal Accounting Officer
- --
- Fergus Fleming
- Chief Technology Officer and Director
- 425.70K
- Dr. Michael J. Donovan, M.D.,PhD
- Chief Medical Officer
- 380.01K
- Howard B. Doran, Jr.
- President
- --
- Daniel Joseph Levangie
- Independent Director
- 200.02K
- Christopher Harwood Bernard Mills
- Independent Director
- --
- Dr. Erik Lium, PhD
- Independent Director
- 204.50K
- Catherine Havlik Coste, C.P.A.
- Independent Director
- 353.15K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data